Medtronic (MDT) Announces Positive, One-Year Clinical Data for Avalus as AVD Treatment

October 3, 2016 11:03 AM EDT Send to a Friend
Medtronic plc (NYSE: MDT) announced positive clinical data for its investigational pericardial aortic surgical valve, intended for the treatment of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to Premium below (Free Trial) LEARN MORE

Member Login